mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |